墨尔本研究人员创造了实验室培育的人类血干细胞,有可能改变白血病和血液紊乱治疗方法。 Melbourne researchers create lab-grown human blood stem cells, potentially transforming leukemia and blood disorder treatments.

墨尔本默多克儿童研究所的研究人员创建了实验室培育的人类血干细胞,这一突破可以改变白血病和其他血液紊乱的治疗方法。 Researchers at Melbourne's Murdoch Children's Research Institute have created lab-grown human blood stem cells, a breakthrough that could transform treatments for leukemia and other blood disorders. 通过使用病人自己的皮肤或血细胞,这种创新可能消除对捐赠干细胞的需求。 This innovation may eliminate the need for donor stem cells by using a patient's own skin or blood cells. 这些结果发表在《自然生物技术》上,为五年内可能进行的临床试验铺平了道路,目的是加强血液治疗的安全性和有效性。 The findings, published in Nature Biotechnology, pave the way for potential clinical trials within five years, aiming to enhance safety and efficacy in blood-related treatments.